Introduction
A clinician needs a screening test to decide whether suspicion of a thyroid disorder is substantiated or not and then requires confirmatory tests before any treatment is begun. The present study was undertaken to decide the best single test or combination for these purposes and, if possible, to select in-vitro tests which avoid radiation exposure.
Patients and Methods Consecutive patients were interviewed when attending Sheffield Royal Infirmary for diagnostic 1311 studies in the investigation of suspected but untreated thyrotoxicosis or hypothyroidism. A full drug history was obtained with confirmation if necessary from the family doctor and a fasting blood sample (20 ml) was taken. The following parameters of thyroid function were used: (1) clinical questionnaire score for thyrotoxicosis (Crooks et al., 1959) or hypothyroidism (Billewicz et al., 1969) ; (2) 4-hour m1t thyroidal uptake value; (3) 48-hour 'RI thyroidal uptake value; (4) 48-hour serum protein bound 1RI level; (5) urinary I3'l excretion (T index) calculation (Fraser et al., 1953) ; (6) overall lrl study assessment; (7) serum protein bound 7I level; (8) serum triiodothyronine (T-3) uptake (Triosorb) value; (9) serum T-3 uptake (Thyopac-3) value; (10) free thyroxine index (Clark and Horn, 1965) derived from parameters 7 and 8.
On completion of all investigations the patients were allocated to three populations (thyrotoxic, euthyroid, or hypothyroid) by two doctors who collated all the test parameters.
Results of investigations in a few patients were difficult to interpret and these "equivocal" results were excluded from initial analysis. Linear discriminant analysis was applied to the results in patients in the three populations. Discriminant analysis creates a decision rule so that arithmetic combinations of laboratory measures classify specific populations (Anderson, 1958 Thyrotoxic v. Euthyroid.-The best combination of two tests was the serum P.B.I. and T-3 uptake values; the addition or substitution of the 4-hour 'III uptake figure did not change the misclassification.
Euthyroid v. Hypothyroid.-Once again the best combination was the two in-vitro tests but the addition of the 48-hour 131I uptake figure improved the classification.
The free thyroxine index was also calculated from the serum P.B.I. and T-3 uptake measurements but the discriminant value of this mathematical derivative was less than the two constituent tests analysed as two variates (table II) . Accordingly, the contribution of each test was retained in a graphical display of the two in-vitro tests (fig 1) on which oblique diagnostic boundaries were derived from the dis- In judging the results of thyroid function tests it is customary to rely on so-called "normal" ranges and limits of each test, which immediately restricts the discriminant value of any combination of tests because each is effectively taken as a single variate. When these test results are contradictory or borderline it is also difficult to decide which is the best discriminant. In this study the clinicians attempted to collate 10 parameters concurrently and to give appropriate weightings when these tests diverged from each other, but some patients were categorized as "equivocal." This approach was clearly inferior to one based on multivariate analysis which considered several variates in combination and chose the best discriminants without reference to the "normal" range of test values. The optimum combination of tests placed these "equivocal" patients in the correct diagnostic category and this was supported by long-term clinical observation. The addition of more variates to the best three tests increased the errors and this explained our difficulties in trying to collate all test results.
The discriminant functions also permitted two innovations in interpreting the test results. Firstly, new graphical boundaries on the Cartesian plot of serum P.B.I. and T-3 uptake values were derived from these mathematical functions which were superior to previously-used limits based on the "normal" range of each test, when many were classed as "equivocal." Secondly, these new boundaries also provided more latitude than older limits and to some extent allowed for drug effects on these tests. For instance, euthyroid women taking an oral contraceptive had raised serum P.B.I. and lowered T-3 uptake values due to changes in thyroxine-binding globulin but these figures were within the lower righthand areas of the new "euthyroid" boundaries. For borderline patients on the plot or nomogram the additional weighting of 131I uptake figures improved the discriminant value of the two in-vitro tests; the 4-hour figure for suspected thyrotoxicosis and the 48-hour one for borderline hypothyroidism. (Oddie, 1971 ) based on laboratory tests alone gave poorer discrimination (90%). These methods also used more test data than our nomogram.
In the present study questionnaires which used clinical symptoms and signs (Crooks et al., 1959; Billewicz et al., 1969) Discriminant analysis can be applied in any situation where several parameters attempt to identify two or more populations but its use in medicine has been limited. Firstly, it can select those tests which place patients into the correct diagnostic category with least risk of error. Secondly, it abandons the "normal" range of each test. Many clinicians have difficulty in accepting this radical change in their interpretation of a group of tests, but the evidence from this and other studies can convince them.
This study has identified the best thyroid function tests for routine clinical use and led to the construction of simple desktop diagnostic aids for interpreting the laboratory test data. We would recommend the combination of serum P.B.I. and T-3 uptake measurements using either of the commercial kits as a screening procedure. The new boundaries would indicate any borderline patients and these together with patients in the thyrotoxic or hypothyroid sections would require further assessment. Physicians usually request confirmatory evidence from a 13ll uptake test before instituting life-long thyroxine replacement or before destructive therapy (thyroid surgery or radioiodine treatment) and the nomogram with the discriminants displayed is the best way of interpreting three tests.
